Skip to main content
. 2023 Apr 4;14:1638. doi: 10.1038/s41467-023-37269-3

Fig. 4. Proteomics analysis of pediatric plasma from patients with acute COVID-19 or post-infectious MIS-C.

Fig. 4

A Overview of untargeted plasma proteomics on sera from pediatric patients with COVID-19 (COVID + ), MIS-C, or healthy controls. B Relative abundance of detected peptides per sample (Healthy n = 7, COVID + n = 7, MIS-C n = 5, SD). C PCA plot of proteomics data for pediatric group. D Venn diagram showing the relative distribution of differentially abundant proteins (DAPs). E Comparison of DAPs to the human genome atlas highlights perturbations in liver and lung; gold reflects MIS-C compared to healthy controls while blue reflects COVID + compared to healthy controls. F KEGG pathway analysis highlights alterations in pathways common between MIS-C and COVID + cohorts. G KEGG pathway analysis of those significant in either MIS-C (gold) or COVID + (blue) highlights perturbations unique to each group, neither of which achieve significance for the fluid shear stress or ECM-receptor interaction pathways identified in the adult cohort. H Heat map of identified DAPs altered upon SARS-CoV-2 infection in children. I The abundance of all 3 chains of the hepatic acute phase protein fibrinogen is not significantly increased in pediatric COVID + or MIS-C patients (Healthy n = 7, COVID + n = 7, MIS-C n = 5, two-way ANOVA, SD). Source data are provided as a Source Data file.